Newsfeeds Archive - Spark Newswire

2 minute read

Nuvectis Pharma’s NXP900 Demonstrates Robust Activity In Non-Small Cell Lung Cancer Cell Lines

April 8, 8:41 AM

Highly Synergistic Antiproliferative Activity in EGFR-resistant Cells in Combination with Osimertinib, the Active Ingredient in TagrissoTMSingle Agent Antiproliferative Activity in Cells Resistant to Alectinib, the

NVCT

1 minute read

Movers

12 Health Care Stocks Moving In Thursday’s Intraday Session

By Benzinga Insights

January 18, 1:31 PM

Gainers Celularity (NASDAQ:CELU) shares moved upwards by 44.7% to $0.27 during Thursday’s regular session. The company’s market cap…

ARAV

2 minute read

Nuvectis Pharma, Inc. Announces A Collaboration With Mayo Clinic To Evaluate NXP800 In An Investigator-Sponsored Clinical Trial In Cholangiocarcinoma

By Benzinga Newsdesk

December 18, 9:06 AM

Mitesh Borad, M.D., will serve as the Principal Investigator for the clinical trialThe Investigator-sponsored clinical trial follows the robust preclinical proof of concept data generated by investigators from Mayo

NVCT

3 minute read

Movers

12 Health Care Stocks Moving In Tuesday’s Intraday Session

By Benzinga Insights

October 17, 1:31 PM

Gainers Nkarta (NASDAQ:NKTX) shares moved upwards by 122.3% to $3.29 during Tuesday’s regular session. Nkarta’s stock is trading…

ANEB

3 minute read

10 Short Squeeze Stocks To Watch: Blue Apron, Intuitive Machines, Yellow Corp, Getty Images And More

By Chris Katje

August 14, 10:49 AM

Potential short squeeze plays gained steam in 2021, continued throughout 2022, and remain a new focus of traders looking for the next huge move. High short interest and steep borrowing costs are among the common traits that could lead to a short squeeze.

APRN